Literature DB >> 2114769

Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT.

G Sze1, E Milano, C Johnson, L Heier.   

Abstract

Contrast-enhanced MR studies were compared with noncontrast MR and contrast-enhanced CT scans in the evaluation of intraparenchymal brain metastases. Fifty consecutive inpatients were studied with short and long repetition time (TR) sequences before and after the administration of gadopentetate dimeglumine. In addition, a delayed short TR sequence was performed. The contrast CT, noncontrast MR, immediate postcontrast short TR sequence, postcontrast long TR sequence, and delayed postcontrast short TR sequence were each read blindly and independently by two neuroradiologists. These results were then compared with a final interpretation, reached by all the neuroradiologists in the study, using all the clinical information and imaging findings. Postcontrast short TR scans proved to be superior to other sequences. They were particularly useful in the detection of metastases in the posterior fossa and cortex. The delayed postcontrast short TR scan held no definite advantage over the immediate postcontrast short TR scan, although metastases were sometimes seen slightly better after the delay. While long TR sequences were not always sensitive or specific, they often did provide ancillary information and were particularly useful in cases of hemorrhagic metastases. Because of these findings, we recommend that the evaluation of intraparenchymal metastases consist of a single postcontrast long TR scan followed by a single postcontrast short TR scan. While these sequences should be very accurate in the detection of metastases, we also generally perform a single precontrast short TR scan as well, since the question of hemorrhage or bone lesion may be clinically relevant.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114769      PMCID: PMC8331625     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  47 in total

Review 1.  Brain imaging.

Authors:  R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

2.  Magnetic resonance imaging in oncology.

Authors:  J E Husband; R Guy
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

3.  Brain Tumor-Enhancement Visualization and Morphometric Assessment: A Comparison of MPRAGE, SPACE, and VIBE MRI Techniques.

Authors:  L Danieli; G C Riccitelli; D Distefano; E Prodi; E Ventura; A Cianfoni; A Kaelin-Lang; M Reinert; E Pravatà
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-20       Impact factor: 3.825

4.  Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients.

Authors:  G Zuccoli; M Gallucci; J Capellades; L Regnicolo; B Tumiati; T Cabada Giadás; W Bottari; J Mandrioli; M Bertolini
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

5.  Colorectal carcinoma and brain metastasis: distribution, treatment, and survival.

Authors:  M A Hammoud; I E McCutcheon; R Elsouki; D Schoppa; Y Z Patt
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

6.  Distortion inherent to magnetic resonance imaging can lead to geometric miss in radiosurgery planning.

Authors:  Tyler M Seibert; Nathan S White; Gwe-Ya Kim; Vitali Moiseenko; Carrie R McDonald; Nikdokht Farid; Hauke Bartsch; Joshua Kuperman; Roshan Karunamuni; Deborah Marshall; Dominic Holland; Parag Sanghvi; Daniel R Simpson; Arno J Mundt; Anders M Dale; Jona A Hattangadi-Gluth
Journal:  Pract Radiat Oncol       Date:  2016-06-01

7.  Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation.

Authors:  Ho-Taek Song; Elaine K Jordan; Bobbi K Lewis; Wei Liu; Justin Ganjei; Brenda Klaunberg; Daryl Despres; Diane Palmieri; Joseph A Frank
Journal:  J Transl Med       Date:  2009-10-20       Impact factor: 5.531

8.  Blindness as an initial presentation of rectal cancer with brain metastases.

Authors:  Tejinder Singh; K V Sajeevan; Ankit Jain; Ullas Batra; K S Saini; C T Satheesh; K C Lakshmaiah; K Govind Babu; D Lokanatha
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

9.  Screening of brain metastasis with limited magnetic resonance imaging (MRI): clinical implications of using limited brain MRI during initial staging for non-small cell lung cancer patients.

Authors:  Sun Young Kim; Jae Sung Kim; Hee Sun Park; Moon June Cho; Ju Ock Kim; Jin Whan Kim; Chang Jun Song; Seung Pyung Lim; Sung Soo Jung
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

Review 10.  Emerging role of brain metastases in the prognosis of breast cancer patients.

Authors:  Amanda Hambrecht; Rahul Jandial; Josh Neman
Journal:  Breast Cancer (Dove Med Press)       Date:  2011-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.